Universität Münster

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis

Not Applicable

Recruiting

Conditions: Multiple Sclerosis, Relapsing-Remitting

Interventions: Dietary Supplement: Vivomixx®
Other: Maltose placebo
Dietary Supplement: Conjugated linoleic acid (CLA/Tonalin® FFA 80)
Other: Sunflower oil placebo

First Posted Date: 2023-06-27

Last Posted Date: 2024-05-08

Lead Sponsor: Universität Münster

Target Recruit Count: 100

Registration Number: NCT05920018

Locations: 🇩🇪
Universitätsklinik Heidelberg, Neurologische Klinik, Heidelberg, BW, Germany
🇩🇪
Neurological study centre, Department of Neurology, Mainz, Hessen, Germany
🇩🇪
IIT unit of the Department of Neurology with Institute of Translational Neurology, Münster, NRW, Germany

and more 1 locations

Differential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery

Recruiting

Conditions: Vasoplegia
Vasoplegic Shock

Interventions: Procedure: on-pump surgery
Procedure: off-pump surgery

First Posted Date: 2023-04-27

Last Posted Date: 2024-12-12

Lead Sponsor: Universität Münster

Target Recruit Count: 40

Registration Number: NCT05833828

Locations: 🇩🇪
Deutsches Herzzentrum der Charité, Berlin, Germany
🇩🇪
University Hospital Münster; Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Münster, Germany

Remote Ischemic Preconditioning in Septic Patients

Not Applicable

Recruiting

Conditions: Critically Ill
Sepsis
Acute Kidney Injury

Interventions: Procedure: Sham RIPC
Procedure: Remote ischemic preconditioning (RIPC)

First Posted Date: 2023-04-26

Last Posted Date: 2024-12-12

Lead Sponsor: Universität Münster

Target Recruit Count: 64

Registration Number: NCT05830669

Locations: 🇩🇪
University Hospital Münster; Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Münster, Germany

tTF-NGR Randomized Study - STS

Phase 3

Recruiting

Conditions: Soft Tissue Sarcoma

Interventions: Drug: Trabectedin
Biological: tTF-NGR

First Posted Date: 2022-10-28

Last Posted Date: 2023-12-22

Lead Sponsor: Universität Münster

Target Recruit Count: 126

Registration Number: NCT05597917

Locations: 🇦🇹
Medizinische Universität Graz, Graz, Austria
🇩🇪
Universitätsklinikum Heidelberg, Heidelberg, Germany
🇩🇪
HELIOS Klinikum Bad Saarow, Bad Saarow, Germany

and more 6 locations

Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor

Phase 1

Recruiting

Conditions: Glioblastoma

Interventions: Drug: Gliolan
Radiation: Radiodynamic therapy

First Posted Date: 2022-10-21

Last Posted Date: 2024-12-16

Lead Sponsor: Universität Münster

Target Recruit Count: 34

Registration Number: NCT05590689

Locations: 🇩🇪
University Hospital Münster, Klinik für Neurochirurgie, Münster, Germany

Reducing Acute Kidney Injury Occurence by Administering Angiotensin II

Phase 3

Completed

Conditions: Cardiac Surgery
Vasoplegia
Hyperreninemia

Interventions: Drug: Control
Drug: Angiotensin II

First Posted Date: 2022-01-20

Last Posted Date: 2023-03-24

Lead Sponsor: Universität Münster

Target Recruit Count: 64

Registration Number: NCT05199493

Locations: 🇩🇪
University Hospital Muenster, Münster, Germany

Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

Phase 2

Recruiting

Conditions: Brain Tumor, Pediatric

Interventions: Drug: 5-Aminolevulinic Acid Hydrochloride, Oral

First Posted Date: 2021-02-04

Last Posted Date: 2024-11-13

Lead Sponsor: Universität Münster

Target Recruit Count: 80

Registration Number: NCT04738162

Locations: 🇩🇪
Universitätsklinikum Augsburg, Klinik für Neurochirurgie, Augsburg, Germany
🇩🇪
Universitätsklinikum Essen, Klinik für Neurochirurgie, Essen, Germany
🇩🇪
Universitätsmedizin Mainz, Klinik und Poliklinik für Neurochirurgie, Mainz, Germany

and more 4 locations

Feasibility and Acceptance of Changes in Medical Supervision of Exercise Groups in Cardiac Rehabilitation

Not Applicable

Completed

Conditions: Rehabilitation Exercise
Cardiac Rehabilitation
Feasibility Studies
Organization and Administration

First Posted Date: 2021-02-04

Last Posted Date: 2021-02-04

Lead Sponsor: Universität Münster

Target Recruit Count: 446

Registration Number: NCT04738383

Locations: 🇩🇪
Instiute of Sport and Exercise Sciences, Münster, North-Rhine Westfalia, Germany
🇩🇪
National Paralympic Committee Germany (NPCG), Frechen, North-Rhine Westfalia, Germany
🇩🇪
Sächsischer Behinderten- und Rehabilitationssportverband e. V., Leipzig, Saxony, Germany

and more 1 locations

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Phase 2

Active, not recruiting

Conditions: Prostatic Neoplasms

Interventions: Other: Standard of care
Drug: Apalutamide 60Mg Tab

First Posted Date: 2020-03-04

Last Posted Date: 2024-06-20

Lead Sponsor: Universität Münster

Target Recruit Count: 190

Registration Number: NCT04295447

Locations: 🇩🇪
GFO Kliniken Rhein-Berg, Bergisch Gladbach, Germany
🇩🇪
Universitätsklinikum Düsseldorf, Düsseldorf, Germany
🇩🇪
Universitätsklinikum Jena, Jena, Germany

and more 18 locations

Natural History of GACI With or Without ARHR2 or PXE

Conditions: Pseudoxanthoma Elasticum
Autosomal Recessive Hypophosphatemic Rickets
Generalized Arterial Calcification in Infancy

First Posted Date: 2018-11-29

Last Posted Date: 2018-11-29

Lead Sponsor: Universität Münster

Target Recruit Count: 80

Registration Number: NCT03758534

Locations: 🇩🇪
WWU Munster, Münster, Germany

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy